Health ❯Healthcare ❯Medical Research

Cancer Research

Immunotherapy Breast Cancer Prostate Cancer Colorectal Cancer Glioblastoma Pancreatic Cancer Multiple Myeloma Triple-Negative Breast Cancer Ovarian Cancer Cancer Immunotherapy

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

The preclinical study points to a selective target for improving AML immunotherapy.

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Genetic Risk Score Flags Future Breast Cancer Risk After DCIS or LCIS

Preclinical Candidate AVJ16 Blocks IGF2BP1 to Halt Lung Tumor Growth in Models

Glycan-Targeting ‘GlyTR’ Therapy Kills Diverse Cancers in Preclinical Tests

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Nanovaccine Targeting Cancer Stem Cells Cuts Post-Surgery Recurrence in Lab Models

Engineered Salmonella Triggers Tumor Immune Hubs, Slows Colorectal Cancer in Mice

Preclinical PET Tracer Enables Same-Day Imaging of Nectin-4 in Breast and Bladder Cancers

VA Study Links Nicotinamide to Lower Skin Cancer Risk, Strongest After First Diagnosis

Low-Dose Aspirin Halves Recurrence in PI3K-Altered Colorectal Cancer, NEJM Trial Finds

Basal Stem-Like Cells Identified as Source of Small Cell Lung Cancer in Duke-Led Nature Study

AI Model Slashes False Positives in Lung CT Screening, Bests PanCan in Multisite Test

Lung Tumors Reprogram Bone Marrow Progenitors as NRF2 Emerges as a Target

Once-Monthly Subcutaneous Amivantamab Plus Lazertinib Shows High Response in Untreated EGFR‑Mutated NSCLC

IFITM3 Identified as Key Modulator of Immunotherapy Response in Small Cell Lung Cancer

Perioperative Immunotherapy and Liquid Biopsy Show Promise in Resectable Mesothelioma Phase 2 Trial

Preclinical Study Highlights HER2 and CD24 as Radiotheranostic Targets in Endometrial Cancer

Urine Test From Johns Hopkins Uses Three Biomarkers to Spot Prostate Cancer With High Accuracy

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial